Subscribe

How did US stock markets respond to Monday's extreme selloff? (+video)

After a brutal trading day to open 2016, US stock indexes recovered Tuesday amid worries surrounding a global slowdown, prompted by speculation on the Chinese economy's stability.

  • close
    The day's numbers are shown on a screen above the floor of the New York Stock Exchange (NYSE) shortly before the closing bell in New York on Monday.
    Lucas Jackson/TPX IMAGES OF THE DAY/Reuters
    View Caption
  • About video ads
    View Caption
of

U.S. stock indexes were higher on Tuesday morning as investors recovered from a bruising selloff on the first trading day of the year.

Stock markets plunged on Monday after weak Chinese economic data rekindled fears of a global slowdown, prompting a near-$20 billion injection by the People's Bank of China to stabilize its markets.

U.S. stocks closed sharply lower on Monday, with the Dow making its worst start to a year since 2008. Weak U.S. factory data also added to the worries.

Global stocks were down on Tuesday but off the lows they hit in the previous session.

"I think everybody's finally getting settled back in and they're trying to assess really how global growth is going to impact their investments for the rest of the year," said Kevin Kelly, CIO of Recon Capital Partners.

"You will see market volatility throughout the rest of the month, but you'll start to see the market have a couple of up days because people are putting money to work," he said.

Crude oil was lower as investors fretted about the state of the Chinese economy, a stronger dollar and rising tensions in the Middle East.

At 9:38 a.m. ET (1438 GMT), the Dow Jones industrial average was up 22.12 points, or 0.13 percent, at 17,171.06, the S&P 500 was up 4.5 points, or 0.22 percent, at 2,017.16 and the Nasdaq Composite index was up 9.26 points, or 0.19 percent, at 4,912.35.

Nine of the 10 major S&P sectors were higher, led by a 0.68 percent rise in health stocks.

Gilead rose 1.2 percent to $99.21 after its experimental hepatitis B drug was found safer than but as effective as its approved treatment, Viread. The stock provided the biggest boost to the S&P 500 and Nasdaq.

First Solar was up 6.5 percent at $71.08 after Goldman Sachs upgraded the stock to "buy."

Advancing issues outnumbered decliners on the NYSE by 1,703 to 958. On the Nasdaq, 1,185 issues rose and 979 fell.

The S&P 500 index showed two new 52-week highs and no new lows, while the Nasdaq recorded six new highs and 11 new lows.

(Reporting by Abhiram Nandakumar in Bengaluru; Editing by Saumyadeb Chakrabarty)

About these ads
Sponsored Content by LockerDome
 
 
Make a Difference
Inspired? Here are some ways to make a difference on this issue.
FREE Newsletters
Get the Monitor stories you care about delivered to your inbox.
 

We want to hear, did we miss an angle we should have covered? Should we come back to this topic? Or just give us a rating for this story. We want to hear from you.

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK